Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1940272 AUSTIN, TX
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,705,573
+$7,387,526 QoQ
Shares Held
3,040,466
+2.0% QoQ
Ownership
0.933%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#22
of 208 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. TSHA ranks #18 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7 CRNX
Crinetics Pharmaceuticals, Inc.
 1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in TSHA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,705,573 3,040,466
2026-03-31 $13,318,047 2,979,429
2025-12-31 $13,726,949 2,495,809
2025-09-30 $9,272,673 2,835,680
2025-06-30 $6,952,799 3,009,870
2025-03-31 $1,482,169 1,066,309
2024-12-31 $307,433 177,707
2024-09-30 $505,314 251,400
2024-06-30 $561,792 250,800
2024-03-31 $124,845 43,500
2023-12-31 $369,930 209,000